[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642009":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":92,"collaborators":10,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":10,"eligibilityCriteria":100,"healthyVolunteers":96,"sex":101,"minAge":102,"maxAge":10,"enrollmentInfo":103,"targetDuration":10,"studyType":106,"phases":10,"briefSummary":107,"conditions":108,"keywords":113,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":120,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Memorial Sloan Kettering Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants with Colorectal Cancer\u002FCRC",null,"Participants will either have symptoms of colorectal cancer\u002FCRC, presented for a screening colonoscopy, or one of the following: pathologic diagnosis of CRC, colonoscopy demonstrating adenomatous polyps, or colonoscopy demonstrating no colon or premalignant or malignant pathology",[13],"Diagnostic Test: 3-metabolite biosensor",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","3-metabolite biosensor","3-metabolite biosensor will identify participants with colorectal cancer (CRC) and precancerous polyps",[9],[21],{"name":22,"affiliation":5,"role":23},"Peter Kingham, MD","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","212-639-5260","kinghamP@mskcc.org",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Alexia Iasonos, PhD","646-227-3557","iasonosa@mskcc.org",[34,49,64,78],{"facility":35,"status":36,"city":37,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Memorial Sloan Kettering Cancer Center (All Protocol Activities)","RECRUITING","New York","10065","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-74.00597,40.71427,{"lat":45,"lon":44},[48],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":10},{"facility":50,"status":51,"city":52,"state":10,"zip":10,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Korle Bu Teaching Hospital (Data Collection Only)","NOT_YET_RECRUITING","Accra","Ghana","GH",{"type":42,"coordinates":56},[57,58],-0.1969,5.55602,{"lat":58,"lon":57},[61],{"name":62,"role":26,"phone":10,"phoneExt":10,"email":63},"Antionette Bediako-Bowan, MD, FWACS, FGCS, PhD","abediako-bowan@ug.edu.gh",{"facility":65,"status":51,"city":66,"state":10,"zip":10,"country":67,"countryCode":68,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Wits Donald Gordon Medical Centre (Data Collection Only)","Johannesburg","South Africa","ZA",{"type":42,"coordinates":70},[71,72],28.04363,-26.20227,{"lat":72,"lon":71},[75],{"name":76,"role":26,"phone":77,"phoneExt":10,"email":10},"Brendan Bebington, MBChB, FCS","011 7263390\u002F1",{"facility":79,"status":51,"city":80,"state":10,"zip":10,"country":81,"countryCode":10,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Kilimanjaro Christian Medical Centre (Data Collection Only)","Moshi","Tanzania",{"type":42,"coordinates":83},[84,85],37.33333,-3.35,{"lat":85,"lon":84},[88],{"name":89,"role":26,"phone":90,"phoneExt":10,"email":91},"Alex Mremi, PhD","+255 717 083 983","alex.mremi@kcmcu.ac.tz",{"type":93,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100642009","a-study-of-a-urine-test-to-detect-colorectal-cancer-100642009",false,"NCT07649057","A Study of a Urine Test to Detect Colorectal Cancer","Determining the Success of a Urine Metabolite Point-of-care Colorectal Cancer Early Diagnosis Test in Africa","Inclusion Criteria:\n\n* Patient presents with one of the following:\n\n  * Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-\n  * Patients who present for a screening colonoscopy -OR-\n  * Has received one of the following within 3 weeks of the planned urine collection\n\n    * Patients with a pathologic diagnosis of CRC either by colonoscopy or resection specimens -OR-\n    * Patients with colonoscopy demonstrating adenomatous polyps -OR-\n    * Patients with colonoscopy demonstrating no colon or premalignant or malignant pathology\n* Age ≥ 18\n* Willingness to participate in the study","ALL","18 Years",{"count":104,"type":105},210,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.",[109,110,111,112],"Colorectal Cancer","Precancerous Polyp","Rectal Bleeding","CRC",[109,110,111,114,112,5,115],"Symptoms of Colorectal Cancer","26-187","2026-06-11",{"date":118,"type":119},"2026-06-15","ACTUAL",{"date":116,"type":119},{"date":122,"type":105},"2028-06-11",{"name":5,"class":6},4]